Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use.
We report a case of a 20-year-old woman with tear deficiency secondary to Stevens Johnson syndrome who developed bilateral corneal melting following use of bromfenac (Xibrom), a nonsteroidal antiinflammatory drug (NSAID), for 2 weeks. The patient presented with complaints of light sensitivity and pain in the right eye. The slitlamp examination revealed a corneal perforation with iris plug in the right eye and an 85% thinned cornea in the left eye. She was admitted to the hospital, where Xibrom was discontinued, therapeutic contact lenses were placed, and a regimen of topical antibiotic agents was instituted. One day after admission, penetrating keratoplasty was performed in the right eye, an amniotic membrane was placed in the left eye, and tarsorrhaphy was performed bilaterally. The clinical features of this case highlight the importance of being selective when administering NSAIDs in patients with a compromised ocular surface.
Isawi
Hanny
H
Cornea and External Disease Service, Pittsburgh, PA, USA.
Dhaliwal
Deepinder K
DK
D000328:Adult; D000650:Amnion / Q000637:transplantation; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001577:Benzophenones / Q000009:adverse effects*; D001969:Bromobenzenes / Q000009:adverse effects*; D003316:Corneal Diseases / Q000139:chemically induced* / Q000601:surgery; D015352:Dry Eye Syndromes / Q000150:complications; D005260:Female; D006801:Humans; D015948:Keratoplasty, Penetrating; D012422:Rupture, Spontaneous / Q000139:chemically induced / Q000601:surgery; D013262:Stevens-Johnson Syndrome / Q000150:complications*; D014792:Visual Acuity
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001577:Benzophenones; D001969:Bromobenzenes; C053083:bromfenac